Diabetes Drug May Cut Heart Disease Risk

A medication prescribed to treat type 2 diabetes may also reduce a person's risk of suffering cardiovascular disease, according to new research at Mount Sinai Hospital in Toronto.

The study found that the drug Jardiance reduced deaths in patients with type 2 diabetes who were at risk of heart attack and stroke.

The research was conducted over a period of three years and included 7,000 people. The results showed that patients taking Jardiance had a 38 percent reduction in cardiovascular death, including from heart attack and stroke. There was no significant difference in non-fatal heart attacks or non-fatal strokes. Also, those taking Jardiance had a 32 percent lower risk of dying from any cause, and a 35 percent lower rate of hospitalizations from heart failure.

Jardiance is a once-a-day pill that won U.S. approval last year. It belongs to a new family of treatments that lower blood sugar by inhibiting reabsorption of glucose in the kidneys. It is the first diabetes drug to show heart-protective results in a large cardiovascular trial.

This Week's Slice of History: Discovery of Bacteria: Sept. 17, 1683

Sourced from: Reuters, Lilly diabetes drug slashes deaths in patients with heart risk